1
|
Ospanov M, León F, Jenis J, Khan IKA, Ibrahim MA. Challenges and future directions of potential natural products leads against 2019-nCoV outbreak. CURRENT PLANT BIOLOGY 2020; 24:100180. [PMID: 33052305 PMCID: PMC7543902 DOI: 10.1016/j.cpb.2020.100180] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 10/01/2020] [Accepted: 10/05/2020] [Indexed: 05/08/2023]
Abstract
Except for Remdesivir® no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir® an small molecule and nucleic acid analogue, it is used to treat adults and children with laboratory confirmed COVID-19, only administrated in hospital settings. Small molecules and particularly natural products count for almost fifty percent of the commercially available drugs, several of them are marketed antiviral agents and those can be a potential agent to treat COVID-19 infections. This short review rationalized different key natural products with known activity against coronaviruses as potential leads against COVID-19.
Collapse
Affiliation(s)
- Meirambek Ospanov
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA
- The Research Center for Medicinal Plants, Al-Farabi Kazakh National University, Al-Farabi ave. 71, 050040, Almaty, Kazakhstan
| | - Francisco León
- Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA
| | - Janar Jenis
- The Research Center for Medicinal Plants, Al-Farabi Kazakh National University, Al-Farabi ave. 71, 050040, Almaty, Kazakhstan
| | - IKhlas A Khan
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA
| | - Mohamed A Ibrahim
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA
- Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12622, Cairo, Egypt
| |
Collapse
|
2
|
Zhang Q, Wang J, He H, Liu H, Yan X, Zou K. Trametenolic Acid B Reverses Multidrug Resistance in Breast Cancer Cells Through Regulating the Expression Level of P-Glycoprotein. Phytother Res 2013; 28:1037-44. [DOI: 10.1002/ptr.5089] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Qiaoyin Zhang
- Hubei Key Laboratory of Natural Products Research and Development; China Three Gorges University; Yichang Hubei 443002 China
| | - Junzhi Wang
- Hubei Key Laboratory of Natural Products Research and Development; China Three Gorges University; Yichang Hubei 443002 China
- Hubei Tujia Institute of Medicine; Yichang Hubei 443002 China
| | - Haibo He
- Hubei Key Laboratory of Natural Products Research and Development; China Three Gorges University; Yichang Hubei 443002 China
| | - Hongbing Liu
- the First People's Hospital of China Three Gorges University; Yichang Hubei 443001 China
| | - Ximing Yan
- Hubei Key Laboratory of Natural Products Research and Development; China Three Gorges University; Yichang Hubei 443002 China
| | - Kun Zou
- Hubei Key Laboratory of Natural Products Research and Development; China Three Gorges University; Yichang Hubei 443002 China
| |
Collapse
|
3
|
Zhan X, Zhang R, Xu Y, Yang S, Xie D, Tan L. Empirical studies about quercetin increasing chemosensitivity on human lung adenocarcinoma cell line A549. ACTA ACUST UNITED AC 2012. [DOI: 10.1007/s10330-012-0998-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|